Awards & Recognitions: Sarepta recognized for innovation and industry leadership

Louise Rodino-Klapac
     Louise Rodino-Klapac, PhD, EVP, 
     Chief Scientific Officer, 
     Head of R&D

When your corporate mission is to engineer precision genetic medicines for rare diseases, innovation is your heartbeat. We’re honored that Sarepta and our approved gene therapy have been recognized for innovation in genetic medicine by a variety of publications and organizations.

Louise Rodino-Klapac, PhD, Executive Vice President, Chief Scientific Officer and Head of R&D, expressed her ambition for rare disease patients and Sarepta’s commitment to advancing innovation for these communities: “I feel incredibly grateful as a scientist and a researcher to do the work that I do every day to develop these medicines and bring them to patients. The great thing about working at Sarepta is how focused we are. We’re working every day for patients. We don’t back down.”


Recent honors include:

fierce pharma


popular science




Sarepta was named winner of the Biotech Innovation category of the 2023 Fierce Life Sciences Innovation Awards.Popular Science named Sarepta and our approved gene therapy to the “Best of What’s New 2023” list in the Health category.  The Cambridge Chamber of Commerce recognized Sarepta with a 2023 Visionary Award. The award celebrates the spirit of discovery and innovation that makes Cambridge unique.